 |
|  |
Nov-21-19 | Downgrade |
Morgan Stanley |
Equal-Weight → Underweight |
$17 → $6 |
|
Nov-20-19 | Resumed |
Guggenheim |
Neutral |
|
|
May-03-19 | Upgrade |
Wedbush |
Neutral → Outperform |
$26 |
|
Apr-12-19 | Initiated |
Guggenheim |
Neutral |
|
|
Feb-07-19 | Upgrade |
Citigroup |
Sell → Buy |
|
|
Feb-07-19 | Downgrade |
Wedbush |
Outperform → Neutral |
|
|
Feb-06-19 | Upgrade |
Raymond James |
Underperform → Mkt Perform |
|
|
Feb-04-19 | Downgrade |
Citigroup |
Neutral → Sell |
$10 |
|
Dec-10-18 | Downgrade |
Raymond James |
Outperform → Underperform |
|
|
Sep-10-18 | Resumed |
BTIG Research |
Buy |
$30 |
|
May-31-18 | Initiated |
Evercore ISI |
Outperform |
$33 |
|
Mar-05-18 | Initiated |
H.C. Wainwright |
Buy |
$38 |
|
Mar-31-17 | Initiated |
Raymond James |
Outperform |
$26 |
|
Mar-02-17 | Initiated |
Instinet |
Buy |
$41 |
|
Dec-20-16 | Initiated |
SunTrust |
Buy |
$30 |
|
Aug-04-16 | Downgrade |
Citigroup |
Buy → Neutral |
|
|
Oct-19-15 | Upgrade |
Citigroup |
Neutral → Buy |
|
|
Sep-17-15 | Initiated |
Citigroup |
Neutral |
$31 |
|
Aug-06-15 | Reiterated |
Stifel |
Buy |
$51 → $56 |
|
Dec-15-14 | Reiterated |
ROTH Capital |
Buy |
$32 → $45 |
|
|
 |
Dec-11-19 10:00AM | MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium GlobeNewswire |
Dec-09-19 03:05PM | MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting GlobeNewswire |
Dec-07-19 08:35AM | The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling Benzinga |
Nov-15-19 12:02PM | We Think MacroGenics (NASDAQ:MGNX) Needs To Drive Business Growth Carefully Simply Wall St. |
Nov-13-19 04:55PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE |
Nov-12-19 01:45PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SNDL, MGNX and OLLI ACCESSWIRE |
12:45PM | FILING FIRM ANNOUNCES DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
10:59AM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, OSTK, RUHN and REZI GlobeNewswire |
10:29AM | TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire |
10:00AM | DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 PR Newswire |
09:36AM | CLASS ACTION UPDATE for SNDL, DBX, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
07:37AM | MacroGenics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile |
03:29AM | Edited Transcript of MGNX earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents |
02:00AM | MGNX DEADLINE TODAY: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts MacroGenics (MGNX) Investors of Todays Deadline to Move for Lead Plaintiff ACCESSWIRE |
Nov-11-19 03:35PM | CLASS ACTION UPDATE for SNDL, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
03:21PM | MacroGenics Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile |
01:45PM | FILING FIRM ANNOUNCES DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
12:15PM | SHAREHOLDER ALERT: UNIT MGNX QUAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
12:00PM | MGNX INVESTOR DEADLINE TOMORROW: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against MacroGenics, Inc. ACCESSWIRE |
10:40AM | DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE |
09:41AM | SHAREHOLDER ALERT: PUMP MGNX VRAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire |
07:10AM | FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of Tomorrows Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE |
Nov-10-19 12:00PM | 2-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm GlobeNewswire |
10:30AM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, SDC and CC ACCESSWIRE |
Nov-09-19 07:35PM | 3-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE |
11:52AM | ROSEN, A LEADING GLOBAL LAW FIRM, Reminds MacroGenics, Inc. Investors of Important November 12th Deadline in Securities Class Action MGNX GlobeNewswire |
Nov-08-19 08:15PM | 4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE |
04:59PM | MGNX NOTICE: Zhang Investor Law Reminds Investors of November 12 Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX GlobeNewswire |
03:00PM | DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 GlobeNewswire |
02:15PM | CLASS ACTION UPDATE for SEE, MGNX and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
01:00PM | 4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE |
11:20AM | SHAREHOLDER ALERT: SEE UNIT MGNX UBER: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire |
10:40AM | SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Deadline: November 12, 2019 ACCESSWIRE |
10:23AM | MacroGenics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile |
09:50AM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, CVET and MYGN ACCESSWIRE |
Nov-07-19 08:05PM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 5-Day Application Deadline is Approaching in Securities Class Action ACCESSWIRE |
05:30PM | SHAREHOLDER ALERT: COF MGNX CVET: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
04:45PM | MacroGenics to Participate in Upcoming Investor Conferences GlobeNewswire |
04:39PM | INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MGNX, ERI, and SNDL of Filing Deadlines GlobeNewswire |
02:15PM | CLASS ACTION UPDATE for UNIT, MGNX and MTCH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
01:30PM | 5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE |
09:25AM | CLASS ACTION UPDATE for PUMP, MGNX, IRBT and TWTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
Nov-06-19 07:50PM | HAGENS BERMAN, SHAREHOLDER ADVOCATES, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 6-Day Application Deadline is Approaching ACCESSWIRE |
06:35PM | MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates Zacks |
06:00PM | DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the Firm PR Newswire |
04:01PM | MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results GlobeNewswire |
03:30PM | SHAREHOLDER ALERT: SNDL MGNX TME: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
02:00PM | SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE |
01:30PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE |
12:15PM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, TME and UBER ACCESSWIRE |
10:39AM | SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE |
09:30AM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PUMP, MGNX, TME and UBER GlobeNewswire |
09:12AM | MacroGenics Announces Flotetuzumab Presentations at the ASH Annual Meeting 2019 GlobeNewswire |
Nov-05-19 08:00PM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys Now, 7-Day Application Deadline is Approaching GlobeNewswire |
04:00PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of UNIT, MGNX and MO ACCESSWIRE |
03:15PM | FIRST FIRM TO FILE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
11:00AM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MDP, MGNX and CVET ACCESSWIRE |
10:00AM | Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against MacroGenics, Inc. (MGNX) and November 12 Deadline Business Wire |
Nov-04-19 08:05PM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies MacroGenics (MGNX) Investors of 8-Day Application Deadline, Encourages Investors Who Suffered Significant Losses to Contact Firm Now ACCESSWIRE |
04:00PM | IMPORTANT REMINDER FOR MACROGENICS, INC. INVESTORS: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the District of Maryland against MacroGenics, Inc. GlobeNewswire |
03:57PM | UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile |
03:10PM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FTCH, UNIT and MGNX ACCESSWIRE |
12:45PM | FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
12:35PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX GlobeNewswire |
12:20PM | CLASS ACTION UPDATE for SNDL, MGNX and OSTK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
10:38AM | SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE |
09:37AM | 3 Medical Product Stocks Likely to Beat This Earnings Season Zacks |
Nov-01-19 03:35PM | SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
03:00PM | Shareholder Alert - Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Actions GlobeNewswire |
01:11PM | INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MGNX, ERI, and SNDL of Filing Deadlines GlobeNewswire |
12:14PM | CLASS ACTION UPDATE for MGNX, MO, MTCH and TWTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
11:29AM | Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX GlobeNewswire |
10:10AM | Investor Alert - Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement ACCESSWIRE |
Oct-31-19 01:00PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, CC and TEUM ACCESSWIRE |
12:45PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
11:40AM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE |
09:41AM | CLASS ACTION UPDATE for ADTN, MDP, MGNX and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
07:00AM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of Securities Class Action: Encourages Investors Who Have Suffered Losses to Contact Firm GlobeNewswire |
Oct-30-19 05:25PM | CLASS ACTION UPDATE for MGNX, MTCH and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
04:05PM | MacroGenics Announces Date of Third Quarter 2019 Financial Results Conference Call GlobeNewswire |
04:00PM | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, ViewRay, Cadence Bancorp, and ProPetro and Encourages Investors to Contact the Firm GlobeNewswire |
02:25PM | SHAREHOLDER ALERT: ADTN MGNX OSTK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
01:10PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
10:45AM | SHAREHOLDER ALERT: COF MDP MGNX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
10:34AM | MacroGenics (MGNX) Expected to Beat Earnings Estimates: Should You Buy? Zacks |
10:09AM | Investor Alert- Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Actions ACCESSWIRE |
Oct-29-19 08:00PM | SHAREHOLDER ALERT: COF MGNX MYGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
07:05PM | Notice of Lead Plaintiff Deadline for Shareholders in the Macrogenics, Inc. Securities Class Action Lawsuit Business Wire |
05:05PM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SNDL, MGNX and CC ACCESSWIRE |
04:20PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
Oct-28-19 09:55PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, OLLI and INFY ACCESSWIRE |
08:21PM | Is MacroGenics Inc (MGNX) Going To Burn These Hedge Funds ? Insider Monkey |
05:35PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
05:14PM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MDP, MGNX and CADE ACCESSWIRE |
04:45PM | ROSEN, A HIGHLY RANKED LAW FIRM, Reminds MacroGenics, Inc. Investors of Important Deadline in Securities Class Action MGNX GlobeNewswire |
10:45AM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, UBER and INFY ACCESSWIRE |
10:08AM | Shareholder Alert - Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Actions ACCESSWIRE |
Oct-27-19 10:25AM | CLASS ACTION UPDATE for MGNX, CADE and INFY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
Oct-25-19 08:05PM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Remind Macrogenics (MGNX) Investors of Securities Class Action: Encourages Investors Who Have Suffered Losses to Contact Firm ACCESSWIRE |
03:49PM | Zhang Investor Law Reminds Investors of November 12 Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX GlobeNewswire |
|
|
|
 |
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. Its pipeline of immuno-oncology product candidates includes Margetuximab, a monoclonal antibody, which is in Phase III clinical trial that targets HER2-expressing tumors, such as various breast and gastroesophageal cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3; MGA012, an anti-PD-1 monoclonal antibody, which inhibits programmed cell death protein 1 (PD-1); MGD013, a monoclonal antibody that targets the immune checkpoints PD-1 and lymphocyte-activation gene 3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and Enoblituzumab, a monoclonal antibody that targets B7-H3. In addition, the company is developing MGD009, a DART molecule that targets B7-H3 expressed on tumor cells and CD3; MGC018, an antibody drug conjugate, which targets solid tumors expressing B7-H3; and MGD007, a DART molecule, which targets glycoprotein A33 and CD3; and MGD014, a DART molecule that targets virus-infected cells. It has strategic collaborations with Incyte Corporation; Les Laboratoires Servier and Institut de Recherches Servier; and Zai Lab Limited. MacroGenics, Inc. was founded in 2000 and is headquartered in Rockville, Maryland. |
 |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Risser Eric Blasius | Sr VP & Chief Business Officer | Sep 27 | Option Exercise | 0.94 | 1,662 | 1,562 | 32,468 | Oct 03 04:33 PM | Risser Eric Blasius | Sr VP & Chief Business Officer | May 22 | Option Exercise | 0.94 | 1,000 | 940 | 31,806 | May 22 04:21 PM | Risser Eric Blasius | Sr VP & Chief Business Officer | May 22 | Sale | 19.03 | 1,000 | 19,026 | 30,806 | May 22 04:21 PM | Risser Eric Blasius | Sr VP & Chief Business Officer | May 20 | Option Exercise | 0.94 | 3,000 | 2,820 | 33,806 | May 22 04:21 PM | Risser Eric Blasius | Sr VP & Chief Business Officer | May 20 | Sale | 18.38 | 3,000 | 55,131 | 30,806 | May 22 04:21 PM | Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 14 | Option Exercise | 0.94 | 2,497 | 2,347 | 30,806 | Mar 18 04:36 PM | Spitznagel Thomas | Sr VP, BPD & Manufacturing | Feb 06 | Option Exercise | 7.51 | 1,770 | 13,293 | 1,770 | Feb 08 05:40 PM | Fust Matthew K | Director | Feb 06 | Option Exercise | 20.15 | 6,924 | 139,519 | 7,424 | Feb 08 05:41 PM | Fust Matthew K | Director | Feb 06 | Sale | 29.38 | 6,924 | 203,427 | 500 | Feb 08 05:41 PM | Spitznagel Thomas | Sr VP, BPD & Manufacturing | Feb 06 | Sale | 30.00 | 1,770 | 53,100 | 0 | Feb 08 05:40 PM | Peters Jeffrey Stuart | General Counsel | Feb 06 | Sale | 30.00 | 68 | 2,040 | 202 | Feb 08 05:40 PM | Risser Eric Blasius | Sr VP & Chief Business Officer | Jan 28 | Option Exercise | 0.94 | 6,000 | 5,640 | 28,309 | Jan 28 04:12 PM | Karrels James | SVP, CFO and Secretary | Jan 24 | Option Exercise | 0.94 | 7,326 | 6,886 | 135,487 | Jan 28 04:10 PM | Karrels James | SVP, CFO and Secretary | Jan 08 | Option Exercise | 0.94 | 5,314 | 4,995 | 128,161 | Jan 10 03:58 PM | Koenig Scott | President and CEO | Jan 03 | Option Exercise | 0.94 | 39,897 | 37,503 | 213,060 | Jan 04 04:29 PM | Karrels James | SVP, CFO and Secretary | Dec 18 | Option Exercise | 0.94 | 5,000 | 4,700 | 122,847 | Dec 20 04:04 PM |
|
 |
|
 |
|